Phosphorus-31 magnetic resonance spectroscopy of skeletal muscle in maternally inherited diabetes and deafness A3243G mitochondrial mutation carriers

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 1, 2009, Pages 127-131

  Van Elderen, Saskia G C ^a   Doornbos, Joost ^a   Van Essen, Einar H R ^a   Lemkes, Herman H P J ^a   Maassen, J Antonie ^a,b   Smit, Jan W A ^a   De Roos, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

31P MRS; A3243G mutation; MIDD

Indexed keywords

C PEPTIDE; CREATINE KINASE; CREATINE PHOSPHATE; GLUCOSE; INSULIN; LACTIC ACID; PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXERCISE; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MALE; MATERNALLY INHERITED DIABETES AND DEAFNESS; MITOCHONDRIAL RESPIRATION; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE; VASTUS MEDIALIS MUSCLE;

ADULT; DEAFNESS; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MITOCHONDRIA, MUSCLE; MITOCHONDRIAL DISEASES; MOTHERS; MUSCLE, SKELETAL; MUTATION; PHOSPHORUS; PHOSPHORUS ISOTOPES;

EID: 60349108598     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21620     Document Type: Article

References (23)

1. Hansrote S, Croul S, Selak M, Kalman B, Schwartzman RJ. External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation. J Neurol Sci 2002;197:63-67.
2. van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992;1:368-371.
3. Murphy R, Turnbull DM, Walker M, Hattersley AT. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 2008;25:383-399.
4. Guillausseau PJ, Massin P, Dubois-Laforgue D, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med 2001;134:721-728.
5. Maassen JA. Mitochondrial diabetes: pathophysiology, clinical presentation, and genetic analysis. Am J Med Genet 2002;115:66-70.
6. Suzuki Y, Taniyama M, Muramatsu T, et al. Diabetes mellitus associated with 3243 mitochondrial tRNA(Leu(UUR)) mutation: clinical features and coenzyme Q10 treatment. Mol Aspects Med 1997;18 Suppl:S181-S188.
7. Takano M, Fujita N, Kamoi K, Makino K, Nagai H. Exercises on a bicycle ergometer in a family of diabetes mellitus associated with a mutation of mitochondrial DNA. Rinsho Shinkeigaku 1998;38:683-685.
8. Arnold DL, Taylor DJ, Radda GK. Investigation ofhuman mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1985;18:189-196.
9. Kuhl CK, Layer G, Traber F, Zierz S, Block W, Reiser M. Mitochondrial encephalomyopathy: correlation of P-31 exercise MR spectroscopy with clinical findings. Radiology 1994;192:223-230.
10. Mattei JP, Bendahan D, Cozzone P. P-31 magnetic resonance spectroscopy. A tool for diagnostic purposes and pathophysiological insights in muscle diseases. Reumatismo 2004;56:9-14.
11. Taylor DJ, Kemp GJ, Radda GK. Bioenergetics ofskeletal muscle in mitochondrial myopathy. J Neurol Sci 1994;127:198-206.
12. Barbiroli B, Iotti S, Lodi R. Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors 1999;9:253-260.
13. Chinnery PF, Taylor DJ, Brown DT, Manners D, Styles P, Lodi R. Very low levels of the mtDNA A3243G mutation associated with mitochondrial dysfunction in vivo. Ann Neurol 2000;47:381-384.
14. Chinnery PF, Taylor DJ, Manners D, Styles P, Lodi R. No correlation between muscle A3243G mutation load and mitochondrial function in vivo. Neurology 2001;56:1101-1104.
15. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007;50:113-120.
16. Schrauwen-Hinderling VB, Roden M, Kooi ME, Hesselink MK, Schrauwen P. Muscular mitochondrial dysfunction and type 2 diabetes mellitus. Curr Opin Clin Nutr Metab Care 2007;10:698-703.
17. De Feyter HM, van den Broek NM, Praet SF, NicolayK, van Loon LJ, Prompers JJ. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol 2008;158:643-653.
18. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142.
19. Szendroedi J, Schmid AI, Chmelik M, et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 2007;4:e154.
20. Vanhamme L, van den BA, Van HS. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
21. Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed 2007;20:555-565.
22. Kushmerick MJ, Meyer RA, Brown TR. Regulation of oxygen consumption in fast- and slow-twitch muscle. Am J Physiol 1992;263:C598-C606.
23. Quistorff B, Johansen L, Sahlin K. Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Bio-chem J 1993;291(Pt 3):681-686.